Skip to main content
. 2024 Mar 18;14(3):361. doi: 10.3390/biom14030361

Figure 6.

Figure 6

(a) Joint conformational placement of isorhamnetin (green), luteolin (blue), and celecoxib (yellow) in the active site of COX-2; and (b) interaction of 4,5-dicaffeoylquinic acid with amino acid residues of COX-2.